The dihydropyridine dexniguldipine hydrochloride inhibits cleavage and religation reactions of eukaryotic DNA topoisomerase I

Biochemistry

Volumn 36, Issue 35, 1997, Pages 10777-10783

  Straub, Tobias ^a   Boesenberg, Charlotte ^a   Gekeler, Volker ^b   Boege, Fritz ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b ALTANA PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; DEXNIGULDIPINE; DIHYDROPYRIDINE DERIVATIVE; DNA TOPOISOMERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; DNA REPLICATION; ENANTIOMER; ENZYME ACTIVITY; EUKARYOTE; LIGATION; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; DIHYDROPYRIDINES; DNA REPLICATION; DNA TOPOISOMERASES, TYPE I; ENZYME STABILITY; HUMANS; KINETICS; RECOMBINANT PROTEINS;

ANIMALIA; EUKARYOTA;

EID: 0030771993     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi970417q     Document Type: Article

References (37)

1. Abdallah, F., & Gietzen, K. (1990) Naunvn-Schmiedebergs Arch. Pharmacol. 341, 45.
2. Aflalo, E., Iftach, S., Segal, S., Gazit, A., & Priel, E. (1994) Cancer Res. 262, 5138-5142.
3. Alsner, J., Kjeldsen, E., Svejstrup, J., Christiansen, K., & Westergaard, O. (1991) in Cellular Regulation by Protein Phosphorylation (Heilmeyer, L. M. G. J., Ed.) pp 429-433, Springer Verlag, Berlin and Heidelberg, Germany.
4. Avemann, K., Knippers, R., Koller, T., & Sogo, J. M. (1988) Mol. Cell. Biol. 8, 3026-3034.
5. Bjornsti, M. A., Benedetti, P., Viglianti, G. A., & Wang, J. C. (1989) Cancer Res. 49, 6318-6323.
6. Boege, F. (1996) Eur. J. Clin. Chem. Clin. Biochem. 34, 873-888.
7. Boege, F., Straub, T., Kehr, A., Boesenberg, C., Christiansen, K., Andersen, A., Jakob, F., & Köhrle, J. (1996) J. Biol.Chem 271, 2262-2270.
8. Boer, R., Grassegger, A., Schudt, C., & Glossmann, H. (1989) Eur. J. Pharmacol. 172, 131-145.
9. Bronstein, I. B., Shuster, A. M., Gololobov, G. V., Gromova, I. I., Kvashuk, O. A., Belostotskaya, K. M., Alekberova, Z. S., Prokaeva, T. B., & Gabibov, A. G. (1992) FEBS Lett. 314, 259-263.
10. Cortes, F., Pinero, J., & Ortiz, T. (1993) Mutat. Res. 303, 71-76.
11. Gekeler, V., Engelcke, M., Probst, G., Ise, W., Wilish, A., Hofmann, J., & Probst, H. (1994) Anti-Cancer Drugs 5 (Suppl. 1), 5.
12. Gietzen, K., Abdallah, F., & Bai, G. (1990) Med. Sci. Res. 18, 627-629.
13. Hecht, S. M., Berry, D. E., Mac, K. L., Busby, R. W., & Nasuti, C. A. (1992) J. Nat. Prod. 55, 401-413.
14. Hertzberg, R. P., Caranfa, M. J., & Hecht, S. M. (1989) Biochemistry 28, 4629-4638.
15. Hill, B. T., & Hosking, L. K. (1994) Cancer Chemother. Pharmacol. 33, 317-324.
16. Hofmann, J., Ueberall, F., Egle, A., & Grunicke, H. (1991) Int. J. Cancer 47, 870-874.
17. Hofmann, J., Wolf, A., Spitaler, M., Bock, G., Drach, J., Ludescher, C., & Grunicke, H. (1992) J. Cancer Res. Clin. Oncol. 118, 361-366.
18. Hofmann, J., Gekeler, V., Ise, W., Noller, A., Mitterdorfer, J., Hofer, S., Utz, I., Gotwald, M., Boer, R., Glossmann, H., & Grunicke, H. (1995) Biochem. Pharmacol. 49, 603-609.
19. Höllt, V., Kouba, M., Dietel, M., & Vogt, G. (1992) Biochem. Pharmacol. 43, 2601-2608.
20. Hsiang, Y.-H., Lihou, M. G., & Liu, L. F. (1989) Cancer Res. 49, 5077-5082.
21. Huebel, U., Hamann, H., & Reznik, G. (1990) J. Cancer Res. Clin. Oncol. 116 (Suppl.), 446.
22. Knudsen, B. R., Straub, T., & Boege, F. (1996) J. Chromatogr. B 684, 307-321.
23. Kudinov, A. R., Bronstein, I. B., Gabibov, A. G., & Gololobov, G. V. (1992) FEBS Lett. 314, 267-270.
24. Malkhandi, J., Ferry, D., Boer, R., Gekeler, V., Ise, W., & Kerr, D. (1994) Eur. J. Pharmacol. 288, 105-114.
25. Nüssler, V., Pelka-Fleischer, R., Zwierzina, H., Nerl, C., Beckert, B., Gullis, E., Gieseler, F., Bock, S., Bartl, R., Petrides, P. E., & et al. (1994) Ann. Hematol 69 (Suppl. 1), S25-S29.
26. Pommier, Y., Kohlhagen, G., Kohn, K., F, L., Wani, M., & Wall, M. (1995) Proc. Natl. Acad. Sci. U.S.A. 92, 8861-8865.
27. Reymann, A., Looft, G., Woermann, C., Dietel, M., & Erttmann, R. (1993) Cancer Chemother. Pharmacol. 32, 25-30.
28. Sanders, K. H., Boer, R., Eltze, M., & Galvan, M. (1988) Arch. Pharmacol. 338 (Suppl.), R38.
29. Scheulen, M., Meusers, P., Schröder, J., Uppenkamp, M., Skorzec, M., Weimar, C., Brittinger, G., & Seeber, S. (1993) Proc. Am. Soc. Clin. Oncol. 12, 1012.
30. Schuller, H. M. (1992) Cancer Res. 52, 2723s-2726s.
31. Schuller, H. M., Correa, E., Orloff, M., & Reznik, G. K. (1990) Cancer Res. 50, 1645-1649.
32. Schuller, H. M., Orloff, M., & Reznik, G. K. (1991) Carcinogenesis 12, 2301-2303.
33. Schuller, H. M., Orloff, M., & Reznik, G. K. (1994) J. Cancer Res. Clin. Oncol. 120, 354-358.
34. Svejstrup, J. Q., Christiansen, K., Gromova, I. I., Andersen, A. H., & Westergaard, O. (1991) J. Mol. Biol. 222, 669-678.
35. Thaler, J., Reiter, W., Ludenscher, C., Wörmann, B., Nüssler, V., Gattringer, C., Reiber, C., Weimar, C., & Nowrousian, M. (1993) Ann. Hematology 67 (Suppl.) A 125, 492.
36. Tsao, Y. P., Russo, A., Nyamuswa, G., Silber, R., & Liu, L. F. (1993) Cancer Res. 53, 5908-5914.
37. Uberall, F., Maly, K., Egle, A., Doppler, W., Hofmann, J., & Grunicke, H. H. (1991) Cancer Res. 51, 5821-5825.